TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 40.95
+0.40 (0.99%)
Sep 8, 2026, 1:59 PM CST
TWi Biotechnology Market Cap
TWi Biotechnology has a market cap or net worth of 8.44 billion as of September 8, 2026. Its market cap has increased by 242.45% in one year.
Market Cap
8.44B
Enterprise Value
8.18B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
40.95
ChartMarket Cap Chart
Since December 27, 2016, TWi Biotechnology's market cap has increased from 3.83B to 8.44B, an increase of 120.49%. That is a compound annual growth rate of 8.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 8.44B | 366.79% |
| Dec 31, 2025 | 1.81B | 47.88% |
| Dec 31, 2024 | 1.22B | -0.52% |
| Dec 29, 2023 | 1.23B | 22.02% |
| Dec 30, 2022 | 1.01B | -7.50% |
| Dec 30, 2021 | 1.09B | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 10.00B |
| AP Biosciences | 9.24B |
| Polaris Group | 8.86B |
| Tanvex BioPharma | 8.37B |
| PharmaEngine | 8.19B |
| Locus Cell | 7.90B |
| Acepodia | 7.75B |
| Adimmune | 7.46B |